Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrateGIST Legacy Study: Continued Velzatinib in GIST
NCT07843641Phase 2Not yet recruiting
- Sponsor
- GSK
- Start
- Oct 2026
- Primary completion
- Jan 2031
01
Overview
A Phase 2 trial of velzatinib in gastrointestinal stromal tumor (GIST), sponsored by GSK. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
velzatinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT07843641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843641.